MD 39-AM

CAS No. 72564-74-0

MD 39-AM( MD-39-AM | MD 39 AM | MD39AM )

Catalog No. M17581 CAS No. 72564-74-0

Anticytokinin activity was evaluated by 50% of the callus growth on the medium with kinetin but without anti-cytokinin

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 82 In Stock
2MG 36 In Stock
5MG 55 In Stock
10MG 86 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MD 39-AM
  • Note
    Research use only, not for human use.
  • Brief Description
    Anticytokinin activity was evaluated by 50% of the callus growth on the medium with kinetin but without anti-cytokinin
  • Description
    MD-39-AM is a diuretic agent, impling an increase in the Na+ excretion and showing antihypertensive effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MD-39-AM | MD 39 AM | MD39AM
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72564-74-0
  • Formula Weight
    268.34
  • Molecular Formula
    C14H12N4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CSc1nc2c(cccn2)c(n1)Nc1ccccc1
  • Chemical Name
    2-Methylsulfanyl-N-phenylpyrido[2,3-d]pyrimidin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pérez MJ, et al. Preliminary pharmacokinetics of a new pyridopyrimidine derivative. Arzneimittelforschung. 1991 Jun;41(6):640-4.
molnova catalog
related products
  • AS 1892802

    AS 1892802 is a potent and selective inhibitor of ROCK. AS 1892802 exibits IC50 values of 52nM, 57nM and 122 nM for human ROCK2, rat ROCK2 and human ROCK1, respectively.

  • Zelasudil

    Zelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.

  • Orexin 2 Receptor Ag...

    Orexin 2 Receptor Agonist is an effective (EC50: 23 nM) and OX2R-selective (OX1R/OX2R EC50 ratio: 70) agonist.